Nils Bottler

Venture Partner

Dr. Florian Kainzinger

Managing Partner and Founder

Ruoff, Michael

Partner

26 past transactions

Inflammatix

Series D in 2021
Inflammatix develops novel molecular diagnostics for acute infections and sepsis that work by 'reading' the immune system. It is a molecular diagnostics company developing rapid tests that read the immune system to resolve major clinical and public health challenges. They are initially focused on developing tests for acute bacterial and viral infections, and sepsis based on patent-pending biomarkers exclusively licensed from Stanford University.

Myo

Series A in 2020
Myo is a communication platform for the care market.they are proud to have designed a product with Myo that brings together people in care.their team is always looking for new talents who would like to work on a product for better care.

Vara

Series A in 2020
Developed, tested, and proven in Germany, Vara is a leading AI-powered breast cancer screening company on a mission to find every deadly breast cancer early. Vara’s Artificial Intelligence (AI) technology is embedded within the German Breast Cancer Screening Program and is backed by some of the most respected institutions in breast cancer screening in the world including Cambridge (UK), Memorial Sloan (US), and Karolinska (Sweden). Vara’s clinical evidence has also been published in Lancet Digital Health, demonstrating that Vara-assisted radiologists significantly outperform average radiologists and are able to find cancers that would otherwise have been missed. Vara works with healthcare stakeholders, radiology service providers, and medical doctor networks to improve access to high-quality screening in Germany, Egypt, India and Mexico.

SpinDiag

Series B in 2020
Spindiag provides an easy-to-use, compact, and automated point-of-care system for the broad, fast, and affordable detection of pathogens. It's first product is an automated SARS-CoV-2 test. Spindiag one can be operated with an easy to use and routine-compatible workflow by a nurse. Test results are directly transferred into the patient record. The patented centrifugal-microfluidic test system rapidly provides laboratory-grade PCR results directly from standard patient swab samples. SpinDiag works with your standard Copan ESwab® and allows culture confirmation or other lab tests without the necessity to take a second sample. The complete workflow is fully automated and suitable for operation by ward nurses. It features an ultrafast and highly-sensitive polymerase chain reaction (PCR).

Endodont

Seed Round in 2020
Endodont is develops innovative processes and products for the dental industry. Their first product is designed improve root canal fillings by simply and safely closing the root canal.

Selfapy

Series A in 2020
Selfapy offers a therapy support tool that helps recognize negative patterns of thought and train new behavior. Selfapy is your guided, self-help online course against depression with a personal psychologist as a companion.

Caspar Health

Series A in 2020
Caspar Health enables people to regain their independence after an illness or accident by making digital rehabilitation broadly accessible. For everyone - independent of time and location! We set new standards for digital rehabilitation. With our digital rehabilitation platform and the healthcare professionals of our Caspar Clinic, we enable effective and result-oriented rehabilitation independent of time and location. We are a recognized provider of tele-rehabilitation aftercare through the German Pension Fund (DRV).

Inflammatix

Series C in 2020
Inflammatix develops novel molecular diagnostics for acute infections and sepsis that work by 'reading' the immune system. It is a molecular diagnostics company developing rapid tests that read the immune system to resolve major clinical and public health challenges. They are initially focused on developing tests for acute bacterial and viral infections, and sepsis based on patent-pending biomarkers exclusively licensed from Stanford University.

Newsenselab (M-sense)

Seed Round in 2019
M-sense is a certified medical app to combat migraines and headache. Our goal is to reduce 50% of headache days through a personalized therapy program - all in-app.

First Light Diagnostics

Series A in 2019
First Light Biosciences develops breakthrough automated medical diagnostic products for rapid, sensitive, and cost-effective detection of Healthcare-Associated Infections (HAI). The products address the need for cost-effective and accurate diagnostics to meet the explosive growth in testing. New testing is being driven by clinical studies showing that testing for infectious agents can help to dramatically lower the rate of hospital infections. Based on its proprietary MultiPath detection technology, First Light’s products combine the performance of the most advanced commercial laboratory tests with unprecedented affordability and ease-of-use.

PreOmics

Series A in 2018
PreOmics develops and provides innovative tools for customers around the world for mass spectrometry (MS)-based proteomics using cutting-edge technologies to support researchers in their protein analysis needs. PreOmics is as a spin-off company from the proteomics research group of pioneer Matthias Mann at the Max-Planck Institute of Biochemistry. They at PreOmics develop and provide innovative technologies for mass spectrometry-based proteomics to make your research simply better. Their mission is to provide you with the best possible solutions and at the highest quality to achieve your results faster, easier and in a more robust manner than ever before.

Myo

Seed Round in 2018
Myo is a communication platform for the care market.they are proud to have designed a product with Myo that brings together people in care.their team is always looking for new talents who would like to work on a product for better care.

Inflammatix

Series B in 2018
Inflammatix develops novel molecular diagnostics for acute infections and sepsis that work by 'reading' the immune system. It is a molecular diagnostics company developing rapid tests that read the immune system to resolve major clinical and public health challenges. They are initially focused on developing tests for acute bacterial and viral infections, and sepsis based on patent-pending biomarkers exclusively licensed from Stanford University.

Selfapy

Seed Round in 2018
Selfapy offers a therapy support tool that helps recognize negative patterns of thought and train new behavior. Selfapy is your guided, self-help online course against depression with a personal psychologist as a companion.

Newsenselab (M-sense)

Venture Round in 2018
M-sense is a certified medical app to combat migraines and headache. Our goal is to reduce 50% of headache days through a personalized therapy program - all in-app.

Omnicare Pharma

Private Equity Round in 2017
Omnicare Pharma is a pharmaceutical wholesaler operating that primarily distributes finished medicinal products to compounding pharmacies for the patient-specific production of cancer drugs.

Smarterials

Seed Round in 2017
Smarterials develops Surgical Gloves for enhanced protection. With double barrier and marker functionality, the new gloves replace current double-gloving solutions, help prevent infections and save costs and resources.

Caspar Health

Seed Round in 2017
Caspar Health enables people to regain their independence after an illness or accident by making digital rehabilitation broadly accessible. For everyone - independent of time and location! We set new standards for digital rehabilitation. With our digital rehabilitation platform and the healthcare professionals of our Caspar Clinic, we enable effective and result-oriented rehabilitation independent of time and location. We are a recognized provider of tele-rehabilitation aftercare through the German Pension Fund (DRV).

Endodont

Seed Round in 2017
Endodont is develops innovative processes and products for the dental industry. Their first product is designed improve root canal fillings by simply and safely closing the root canal.

Newsenselab (M-sense)

Venture Round in 2016
M-sense is a certified medical app to combat migraines and headache. Our goal is to reduce 50% of headache days through a personalized therapy program - all in-app.

Hellocare

Seed Round in 2016
HelloCare is an online care and support marketplace that helps users find caregivers and domestic helpers in their cities. People can select the day, time, and the scope of services; receive a personal message with information on the representative or domestic helper assigned for them; visit the online profile of the candidate and see the reviews of other customers; and make payments via online tools to book the service. HelloCare enables independent caregivers and domestic workers to register as partners, access customer orders, and work without a direct boss.

Caspar Health

Seed Round in 2016
Caspar Health enables people to regain their independence after an illness or accident by making digital rehabilitation broadly accessible. For everyone - independent of time and location! We set new standards for digital rehabilitation. With our digital rehabilitation platform and the healthcare professionals of our Caspar Clinic, we enable effective and result-oriented rehabilitation independent of time and location. We are a recognized provider of tele-rehabilitation aftercare through the German Pension Fund (DRV).
HyHelp provides a unique and innovative tool for hygiene management in hospitals and other healthcare institutions. HyHelp´s device helps doctors and nurses to boost hand hygiene, prevent nosocomial infections and improve patient safety.
HyHelp provides a unique and innovative tool for hygiene management in hospitals and other healthcare institutions. HyHelp´s device helps doctors and nurses to boost hand hygiene, prevent nosocomial infections and improve patient safety.

Pedanios

Seed Round in 2015
Pedanios GmbH distributes pharmaceutical products. Peace Naturals is a wholly owned subsidiary of Cronos Group, who, in December of 2016, bolstered Peace Naturals’ existing relationship with Pedanios by entering into an exclusive European supply agreement, which stated that for the initial period of three years Cronos would be the exclusive North American supplier of cannabis products to Pedanios for distribution within the European Union.

Urban Sports Club

Seed Round in 2015
Urban Sports Club offers a flexible sports flatrate. The mission is to help people lead a more healthy and active lifestyle. Club members can choose from more than 50 types of sports – ranging from classic gym workout, swimming, yoga, or bouldering, to team sports, wellness and lots more – and more than 10.000 partner venues in Germany, France, Italy, Spain, Portugal and Belgium. Variety, flexible conditions as well as team sports and wellness are offered both for private customers and companies. Urban Sports GmbH was founded in 2012 by Moritz Kreppel and Benjamin Roth in Berlin, Germany. After two years of bootstrapping, the company secured an early-stage financing in 2015 and went on to acquire four of its German competitors, starting with Somuchmore in December, 2016. In January 2018, FITrate came on board, with INTERFIT following in December of the same year. OneFit joined the Urban Sports Club family in August of 2019.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at support@teaserclub.com. Your feedback is most welcome.